0001209191-22-003715.txt : 20220119
0001209191-22-003715.hdr.sgml : 20220119
20220119162032
ACCESSION NUMBER: 0001209191-22-003715
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220114
FILED AS OF DATE: 20220119
DATE AS OF CHANGE: 20220119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUNN JOHN MICHAEL
CENTRAL INDEX KEY: 0001238648
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33004
FILM NUMBER: 22539025
MAIL ADDRESS:
STREET 1: C/O VITAL THERAPIES, INC.
STREET 2: 15010 AVENUE OF SCIENCE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acer Therapeutics Inc.
CENTRAL INDEX KEY: 0001069308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320426967
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
BUSINESS PHONE: (844) 902-6100
MAIL ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
FORMER COMPANY:
FORMER CONFORMED NAME: Opexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20060616
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaFrontiers Corp.
DATE OF NAME CHANGE: 20051011
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMAFRONTIERS CORP
DATE OF NAME CHANGE: 20040816
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-14
0
0001069308
Acer Therapeutics Inc.
ACER
0001238648
DUNN JOHN MICHAEL
C/O ACER THERAPEUTICS INC.
300 WASHINGTON STREET, STE. 351
NEWTON
MA
02458
1
0
0
0
Stock Option (right to buy)
2.21
2022-01-14
4
A
0
18500
0.00
A
2032-01-14
Common Stock
18500
18500
D
The option vests and becomes exercisable in full on January 14, 2023.
/s/ Harry S. Palmin, Attorney-in-Fact
2022-01-19